Mylan gets FDA approval for antiepileptic Levetiracetam Tablets - Update
Tuesday, November 4th, 2008 Posted in Forex News |Mylan, Inc. (MYL), a diversified generic and specialty pharmaceutical company, said Tuesday the U.S. Food and Drug Administration, or FDA, has granted its subsidiary Mylan Pharmaceuticals Inc. final approval for Levetiracetam Tablets, the generic version of UCB Pharma's antiepileptic Keppra.
